#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Evaluation of Prediction Models for Decision-Making: Beyond Calibration and Discrimination


article has not abstract


Vyšlo v časopise: Evaluation of Prediction Models for Decision-Making: Beyond Calibration and Discrimination. PLoS Med 10(7): e32767. doi:10.1371/journal.pmed.1001491
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001491

Souhrn

article has not abstract


Zdroje

1. PfeifferRM, ParkY, KreimerAR, LaceyJVJr, PeeD, et al. (2013) Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med 10: e1001492 doi:10.1371/journal. pmed.1001492

2. SchwartzLM, WoloshinS, DvorinEL, WelchHG (2006) Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks. BMJ 333: 1248–1250.

3. WareJH (2006) The limitations of risk factors as prognostic tools. New Engl J Med 355: 2615–2616.

4. PepeMS, JanesH, LongtonG, LeisenringW, NewcombP (2004) Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic or screening marker. Am J Epidemiol 159: 882–890.

5. MallettS, HaliganS, ThompsonM, CollinsGS, AltmanDG (2012) Interpreting diagnostic accuracy studies for patient care. BMJ 344: e3999.

6. FallK, GarmoH, AndrénO, Bill-AxelsonA, AdolfssonJ, et al. (2007) Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst 99: 526–532.

7. SteyerbergEW, VickersAJ, CookNR, GerdsT, GonenM, et al. (2010) Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology 21: 128–138.

8. BakerSG, CookNR, VickersA, KramerBS (2009) Using relative utility curves to evaluate risk prediction. J R Soc Ser A Stat Soc 172: 729–748.

9. PencinaMJ, D'AgostinoRB, SteyerbergEW (2011) Extension of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11–21.

10. VickersAJ, ElkinEB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26: 565–574.

11. CookNR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115: 928–935.

12. PencinaMJ, D'AgostinoRBSr, D'AgostinoRBJr, VasanRS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157–172.

13. PepeMS, FengZ, HuangY, LongtonG, PrenticeR, et al. (2007) Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol 167: 362–368.

14. BakerSG (2009) Putting risk prediction in perspective: relative utility curves. J Natl Cancer Inst 101: 1538–1542.

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2013 Číslo 7
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Eozinofilní granulomatóza s polyangiitidou
nový kurz
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#